These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27138766)

  • 1. MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases.
    Li H; Zhai Z; Qu X; Xu J; Qin A; Dai K
    Curr Drug Targets; 2018; 19(5):422-431. PubMed ID: 27138766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclastic microRNAs and their translational potential in skeletal diseases.
    Inoue K; Nakano S; Zhao B
    Semin Immunopathol; 2019 Sep; 41(5):573-582. PubMed ID: 31591677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.
    Ji X; Chen X; Yu X
    Int J Mol Sci; 2016 Mar; 17(3):349. PubMed ID: 27005616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and their roles in osteoclast differentiation.
    Xia Z; Chen C; Chen P; Xie H; Luo X
    Front Med; 2011 Dec; 5(4):414-9. PubMed ID: 22198753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in bone diseases.
    Gennari L; Bianciardi S; Merlotti D
    Osteoporos Int; 2017 Apr; 28(4):1191-1213. PubMed ID: 27904930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts.
    Liu J; Dang L; Li D; Liang C; He X; Wu H; Qian A; Yang Z; Au DW; Chiang MW; Zhang BT; Han Q; Yue KK; Zhang H; Lv C; Pan X; Xu J; Bian Z; Shang P; Tan W; Liang Z; Guo B; Lu A; Zhang G
    Biomaterials; 2015 Jun; 52():148-60. PubMed ID: 25818421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs and post-transcriptional regulation of skeletal development.
    Gámez B; Rodriguez-Carballo E; Ventura F
    J Mol Endocrinol; 2014 Jun; 52(3):R179-97. PubMed ID: 24523514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs in osteoclast biology.
    Weivoda MM; Lee SK; Monroe DG
    Bone; 2021 Feb; 143():115757. PubMed ID: 33212320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs involved in bone formation.
    Papaioannou G; Mirzamohammadi F; Kobayashi T
    Cell Mol Life Sci; 2014 Dec; 71(24):4747-61. PubMed ID: 25108446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.
    Ell B; Mercatali L; Ibrahim T; Campbell N; Schwarzenbach H; Pantel K; Amadori D; Kang Y
    Cancer Cell; 2013 Oct; 24(4):542-56. PubMed ID: 24135284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.
    Zhai Y; Tyagi SC; Tyagi N
    Biomed Pharmacother; 2017 Aug; 92():1073-1084. PubMed ID: 28618652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
    Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
    J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs in osteoblasts differentiation and bone disorders.
    Arfat Y; Xiao WZ; Ahmad M; Zhao F; Li DJ; Sun YL; Hu L; Zhihao C; Zhang G; Iftikhar S; Shang P; Yang TM; Qian AR
    Curr Med Chem; 2015; 22(6):748-58. PubMed ID: 25386816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.
    de la Rica L; García-Gómez A; Comet NR; Rodríguez-Ubreva J; Ciudad L; Vento-Tormo R; Company C; Álvarez-Errico D; García M; Gómez-Vaquero C; Ballestar E
    Genome Biol; 2015 Jan; 16(1):2. PubMed ID: 25601191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNAs in bone diseases.
    Moore BT; Xiao P
    Microrna; 2013; 2(1):20-31. PubMed ID: 25070712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A review on microRNAs regulation in osteoclast differentiation and function].
    Lian J; Du W; Meng S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):543-7. PubMed ID: 26688953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-26a regulates RANKL-induced osteoclast formation.
    Kim K; Kim JH; Kim I; Lee J; Seong S; Park YW; Kim N
    Mol Cells; 2015 Jan; 38(1):75-80. PubMed ID: 25518928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review).
    Valenti MT; Dalle Carbonare L; Mottes M
    Int J Mol Med; 2018 May; 41(5):2441-2449. PubMed ID: 29393379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.